StockData
Kiora Pharmaceuticals Inc logo

Kiora Pharmaceuticals Inc (KPRX) stock

KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$0.93−0.05 (-5.30%)

Close on Nov 17, 2026Market cap $4.11MP/E –Yield –

Kiora Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Kiora Pharmaceuticals's enterprise value was -$10.86M on Nov 11, 2026, against -$12.58M a year earlier. Over the last 5 years it ranged from -$19.26M to $148.38M, with a median of -$3.88M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$10.86M–
2025Dec 31, 2025-$12.62M–
2024Dec 31, 2024-$19.14M–
2023Dec 29, 2023-$1.39M-101.0%
2022Dec 30, 2022$143.20M+1825.0%
2021Dec 31, 2021$7.44M-62.0%
2020Dec 31, 2020$19.56M-28.1%
2019Dec 31, 2019$27.18M-90.5%
2018Dec 31, 2018$285.74M+9.8%
2017Dec 29, 2017$260.14M+16.7%
2016Dec 30, 2016$222.97M-24.9%
2015Dec 31, 2015$297.01M–

More Kiora Pharmaceuticals figures

See a number that looks wrong?